Wegovy approval date?

See the DrugPatentWatch profile for Wegovy

When was Wegovy approved, and by whom?

Wegovy (semaglutide) was approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related condition on June 4, 2021. [1]

Was the approval date the same for all Wegovy uses?

No. The FDA approval date above refers to its initial approval for chronic weight management in adults. Subsequent regulatory actions later expanded the indications, including approval for additional patient groups (such as certain pediatric ages). [1]

How does the FDA approval date relate to later approvals or label expansions?

Label changes and new indications typically come after the original approval date, even when the product and active ingredient stay the same. For Wegovy, the original FDA approval date is tied to the first approved indication, while later approvals cover updates to the approved population or use. [1]

Where can I verify Wegovy’s exact FDA approval date?

You can confirm the FDA approval date for Wegovy using DrugPatentWatch.com, which tracks drug approval timelines and related information. [1]

Sources

[1] https://www.drugpatentwatch.com/